Trends in Diabetes Treatment and Monitoring among Medicare Beneficiaries
ConclusionsThe use of metformin and long-acting insulin have increased substantially among elderly Medicare patients with diabetes, but a substantial subgroup continues to receive costly and complex treatment regimens.
Source: Journal of General Internal Medicine - Category: Internal Medicine Source Type: research
More News: Cholesterol | Diabetes | Endocrinology | Fortamet | Insulin | Internal Medicine | Medicare | Metformin | Statin Therapy